1. Home
  2. YAAS vs NEUP Comparison

YAAS vs NEUP Comparison

Compare YAAS & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YAAS
  • NEUP
  • Stock Information
  • Founded
  • YAAS 2018
  • NEUP 1996
  • Country
  • YAAS China
  • NEUP United States
  • Employees
  • YAAS N/A
  • NEUP N/A
  • Industry
  • YAAS Computer Software: Prepackaged Software
  • NEUP
  • Sector
  • YAAS Technology
  • NEUP
  • Exchange
  • YAAS Nasdaq
  • NEUP Nasdaq
  • Market Cap
  • YAAS 9.5M
  • NEUP 10.3M
  • IPO Year
  • YAAS 2024
  • NEUP N/A
  • Fundamental
  • Price
  • YAAS $1.51
  • NEUP $4.39
  • Analyst Decision
  • YAAS
  • NEUP Strong Buy
  • Analyst Count
  • YAAS 0
  • NEUP 2
  • Target Price
  • YAAS N/A
  • NEUP $28.00
  • AVG Volume (30 Days)
  • YAAS 55.6K
  • NEUP 4.6M
  • Earning Date
  • YAAS 07-14-2025
  • NEUP 11-14-2025
  • Dividend Yield
  • YAAS N/A
  • NEUP N/A
  • EPS Growth
  • YAAS N/A
  • NEUP N/A
  • EPS
  • YAAS N/A
  • NEUP N/A
  • Revenue
  • YAAS $581,862.00
  • NEUP $15,649,448.00
  • Revenue This Year
  • YAAS N/A
  • NEUP N/A
  • Revenue Next Year
  • YAAS N/A
  • NEUP N/A
  • P/E Ratio
  • YAAS N/A
  • NEUP N/A
  • Revenue Growth
  • YAAS N/A
  • NEUP N/A
  • 52 Week Low
  • YAAS $1.49
  • NEUP $2.90
  • 52 Week High
  • YAAS $560.00
  • NEUP $21.40
  • Technical
  • Relative Strength Index (RSI)
  • YAAS 35.85
  • NEUP 35.24
  • Support Level
  • YAAS $1.49
  • NEUP $4.36
  • Resistance Level
  • YAAS $2.52
  • NEUP $5.00
  • Average True Range (ATR)
  • YAAS 0.14
  • NEUP 0.39
  • MACD
  • YAAS -0.07
  • NEUP 0.29
  • Stochastic Oscillator
  • YAAS 3.26
  • NEUP 37.60

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: